Point72 Middle East FZE »

Ionis Pharmaceuticals shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $505k 10k 50.59
2023-09-30 $831k 18k 45.36
2023-06-30 $669k 16k 41.03

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Ionis Pharmaceuticals

Vanguard Group
Bellevue Group
ClearBridge Advisors
Wellington Management Company
T. Rowe Price Associates
Tweedy, Browne Company
BVF
OrbiMed Advisors
ARK Investment Management
Charles Schwab Investment Management
Norges Bank Investment Management
Point72 Asset Management
Jpmorgan Chase & Co
Candriam Luxembourg S.C.A.
TD Asset Management

View all funds holding Ionis Pharmaceuticals